Delving into the Latest Updates on Huangshi Yanwu Pharmaceutical Co. Ltd. with Synapse

Overview

Tags

Other Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

No Data

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Top 5 Drug Type	Count

Small molecule drug	1

Top 5 Target	Count

PFOR(Pyruvate synthase)	1

A safety evaluation was conducted by comparing the pharmacokinetics of a single oral dose of the test preparation, potassium citrate bismuth granules produced by Hubei Huquan Pharmaceutical, and the reference preparation, potassium citrate bismuth tablets (trade name: Gastrodenol) produced by Tora Laboratories S.L. of Spain, in healthy adult subjects in China.

Start Date21 Dec 2021

Sponsor / Collaborator

Tiger Chuen Hubei Pharmaceutical Co. Ltd.

100 Clinical Results associated with Huangshi Yanwu Pharmaceutical Co. Ltd.

Login to view more data

0 Patents (Medical) associated with Huangshi Yanwu Pharmaceutical Co. Ltd.

Login to view more data

1

Literatures (Medical) associated with Huangshi Yanwu Pharmaceutical Co. Ltd.

01 Jan 2000·Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials

[Advances in the study of danggui shaoyao powder].

Review

Author: Tao, Z

100 Deals associated with Huangshi Yanwu Pharmaceutical Co. Ltd.

Login to view more data

100 Translational Medicine associated with Huangshi Yanwu Pharmaceutical Co. Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 05 Oct 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Approved

1

Login to view more data